Complete Revascularization: A Quality-Performance Metric?∗
作者： Dean J. Kereiakes
DOI: 10.1016/J.JACC.2013.05.034
关键词: Quality performance 、 Meta-analysis 、 Metric (unit) 、 Medicine 、 Artery 、 Percutaneous coronary intervention 、 Internal medicine 、 Conventional PCI 、 Coronary artery disease 、 Revascularization 、 Cardiology
摘要: Current U.S. and European guidelines recommend coronary artery bypass graft (CABG) over percutaneous intervention (PCI) for multivessel disease (CAD) confer a class IIb (of uncertain benefit) recommendation to PCI improvement in survival [(1,2)][1]. Prior studies
onlinejacc.org参考文章(21)
Gregg W Stone, Ali Rizvi, Krishnankutty Sudhir, William Newman, Robert J Applegate, Louis A Cannon, James T Maddux, Donald E Cutlip, Charles A Simonton, Poornima Sood, Dean J Kereiakes, SPIRIT IV Investigators, Randomized Comparison of Everolimus- and Paclitaxel-Eluting Stents: 2-Year Follow-Up From the SPIRIT (Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System) IV Trial Journal of the American College of Cardiology. ,vol. 58, pp. 19- 25 ,(2011) , 10.1016/J.JACC.2011.02.022
Edward L. Hannan, Chuntao Wu, Gary Walford, David R. Holmes, Robert H. Jones, Samin Sharma, Spencer B. King, Incomplete Revascularization in the Era of Drug-Eluting Stents JACC: Cardiovascular Interventions. ,vol. 2, pp. 17- 25 ,(2009) , 10.1016/J.JCIN.2008.08.021
Usman Baber, Roxana Mehran, Samin K. Sharma, Somjot Brar, Jennifer Yu, Jung-Won Suh, Hyo-Soo Kim, Seung-Jung Park, Adnan Kastrati, Antoinette de Waha, Prakash Krishnan, Pedro Moreno, Joseph Sweeny, Michael C. Kim, Javed Suleman, Robert Pyo, Jose Wiley, Jason Kovacic, Annapoorna S. Kini, George D. Dangas, Impact of the Everolimus-Eluting Stent on Stent Thrombosis Journal of the American College of Cardiology. ,vol. 58, pp. 1569- 1577 ,(2011) , 10.1016/J.JACC.2011.06.049
Philippe Généreux, Tullio Palmerini, Adriano Caixeta, Gregg Rosner, Philip Green, Ovidiu Dressler, Ke Xu, Helen Parise, Roxana Mehran, Patrick W. Serruys, Gregg W. Stone, Quantification and Impact of Untreated Coronary Artery Disease After Percutaneous Coronary Intervention: The Residual SYNTAX (Synergy Between PCI With Taxus and Cardiac Surgery) Score Journal of the American College of Cardiology. ,vol. 59, pp. 2165- 2174 ,(2012) , 10.1016/J.JACC.2012.03.010
Davide Capodanno, Alberto Chisari, Daniele Giacoppo, Salvatore Bonura, Vincenzo Lavanco, Piera Capranzano, Anna Caggegi, Margherita Ministeri, Corrado Tamburino, Objectifying the impact of incomplete revascularization by repeat angiographic risk assessment with the residual SYNTAX score after left main coronary artery percutaneous coronary intervention. Catheterization and Cardiovascular Interventions. ,vol. 82, pp. 333- 340 ,(2013) , 10.1002/CCD.24642
Michael E Farkouh, Michael Domanski, Lynn A Sleeper, Flora S Siami, George Dangas, Michael Mack, May Yang, David J Cohen, Yves Rosenberg, Scott D Solomon, Akshay S Desai, Bernard J Gersh, Elizabeth A Magnuson, Alexandra Lansky, Robin Boineau, Jesse Weinberger, Krishnan Ramanathan, J Eduardo Sousa, Jamie Rankin, Balram Bhargava, John Buse, Whady Hueb, Craig R Smith, Victoria Muratov, Sameer Bansilal, Spencer King III, Michel Bertrand, Valentin Fuster, None, Strategies for Multivessel Revascularization in Patients with Diabetes The New England Journal of Medicine. ,vol. 367, pp. 2375- 2384 ,(2012) , 10.1056/NEJMOA1211585
Dean Kereiakes, Pieter C. Smits, Elvin Kedhi, Helen Parise, Martin Fahy, Patrick W. Serruys, Gregg W. Stone, Predictors of death or myocardial infarction, ischaemic-driven revascularisation, and major adverse cardiovascular events following everolimus-eluting or paclitaxel-eluting stent deployment: pooled analysis from the SPIRIT II, III, IV and COMPARE trials. Eurointervention. ,vol. 7, pp. 74- 83 ,(2011) , 10.4244/EIJV7I1A14
Dean J. Kereiakes, Krishnankutty Sudhir, James B. Hermiller, Paul C. Gordon, Joanne Ferguson, Manejeh Yaqub, Poornima Sood, Xiaolu Su, Steven Yakubov, Alexandra J. Lansky, Gregg W. Stone, Comparison of Everolimus-Eluting and Paclitaxel-Eluting Coronary Stents in Patients Undergoing Multilesion and Multivessel Intervention Jacc-cardiovascular Interventions. ,vol. 3, pp. 1229- 1239 ,(2010) , 10.1016/J.JCIN.2010.09.014
Young-Hak Kim, Duk-Woo Park, Jong-Young Lee, Won-Jang Kim, Sung-Cheol Yun, Jung-Min Ahn, Hae Geun Song, Jun-Hyok Oh, Jong Seon Park, Soo-Jin Kang, Seung-Whan Lee, Cheol Whan Lee, Seong-Wook Park, Seung-Jung Park, Impact of Angiographic Complete Revascularization After Drug-Eluting Stent Implantation or Coronary Artery Bypass Graft Surgery for Multivessel Coronary Artery Disease Circulation. ,vol. 123, pp. 2373- 2381 ,(2011) , 10.1161/CIRCULATIONAHA.110.005041
Sripal Bangalore, Sunil Kumar, Mario Fusaro, Nicholas Amoroso, Michael J. Attubato, Frederick Feit, Deepak L. Bhatt, James Slater, Short- and Long-Term Outcomes With Drug-Eluting and Bare-Metal Coronary Stents Circulation. ,vol. 125, pp. 2873- 2891 ,(2012) , 10.1161/CIRCULATIONAHA.112.097014